TD Asset Management
CNST

TD Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

TD Asset Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-37,603
Closed -$880K – 1627
2021
Q1 		$880K Buy
37,603
+22,203
+144% +$673K ﹤0.01% 1286
2020
Q4 		$444K Hold
15,400
– – ﹤0.01% 1351
2020
Q3 		$312K Hold
15,400
– – ﹤0.01% 1310
2020
Q2 		$463K Hold
15,400
– – ﹤0.01% 1229
2020
Q1 		$484K Buy
15,400
+500
+3% +$17.4K ﹤0.01% 1177
2019
Q4 		$702K Buy
+14,900
New +$430K ﹤0.01% 1181

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management's CNST Position: Q2 2021 in Review

TD Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 37,603 shares — an estimated $880K sold.

TD Asset Management first reported a position in CNST in Q4 2019 and held it in 6 quarters. The position peaked at $880K in Q1 2021. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • TD Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • TD Asset Management sold 37,603 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $880K.
  • TD Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 6 quarters.
  • TD Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $880K in Q1 2021.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on TD Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.